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Abstract
Introduction: Fetal changes in DNA methylation may underlie associations of maternal smoking 
during pregnancy with adverse outcomes in children. We examined critical periods and doses of 
maternal smoking during pregnancy in relation to newborn DNA methylation, and associations of 
paternal smoking with newborn DNA methylation.
Aims and Methods: This study was embedded in the Generation R Study, a population-based 
prospective cohort study from early pregnancy onwards. We assessed parental smoking during 
pregnancy using questionnaires. We analyzed associations of prenatal smoke exposure with new-
born DNA methylation at 5915 known maternal smoking-related cytosine-phosphate-guanine sites 
(CpGs) in 1261 newborns using linear regression. Associations with false discovery rate-corrected 
p-values < .05 were taken forward.
Results: Sustained maternal smoking was associated with newborn DNA methylation at 1391 
CpGs, compared with never smoking. Neither quitting smoking early in pregnancy nor former 
smoking was associated with DNA methylation, compared with never smoking. Among sustained 
smokers, smoking ≥5, compared with <5, cigarettes/d was associated with DNA methylation at 
seven CpGs. Paternal smoking was not associated with DNA methylation, independent of maternal 
smoking status.
Conclusions: Our results suggest that CpGs associated with sustained maternal smoking are not 
associated with maternal smoking earlier in pregnancy or with paternal smoking. Some of these 
CpGs show dose–response relationships with sustained maternal smoking. The third trimester 
may comprise a critical period for associations of smoking with newborn DNA methylation, or 
sustained smoking may reflect higher cumulative doses. Alternatively, maternal smoking limited 
to early pregnancy and paternal smoking may be associated with DNA methylation at specific 
other CpGs not studied here.
Implications: Our results suggest that quitting maternal smoking before the third trimester of 
pregnancy, and possibly lowering smoking dose, may prevent differential DNA methylation in the 
newborns at CpGs associated with sustained smoking. If the relevance of DNA methylation for 
clinical outcomes is established, these results may help in counseling parents-to-be about quitting 
smoking.
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Introduction
Maternal smoking during pregnancy is associated with adverse 
child health outcomes.1,2 There is little information on critical time-
windows or critical doses for prenatal smoke exposure. Observational 
studies suggest that smoking restricted to early pregnancy and low 
doses may have limited impact on newborn development.2–4
DNA methylation may underlie associations of prenatal 
smoke exposure and adverse outcomes. A  large meta-analysis of 
epigenome-wide association studies (EWAS) showed associations 
of sustained smoking in pregnancy with cord blood DNA methy-
lation at 6073 cytosine-phosphate-guanine sites (CpGs).5 Only few 
studies explored associations of timing and dose of prenatal smoke 
exposure with newborn DNA methylation, either epigenome-wide 
or at specific candidate CpGs.6–10 These suggested effects of timing or 
dose on DNA methylation, but maternal smoking timing was often 
not assessed in detail. Specifically, differentiating between mothers 
who never smoked, quit before pregnancy, or quit early in pregnancy 
could be informative. Associations of paternal smoking with new-
born DNA methylation could reflect either transmission through 
the sperm epigenome or in utero exposure to maternal second-hand 
smoking. One previous study examined paternal smoking at 26 ma-
ternal smoking-related CpGs, but found no associations.10
In this hypothesis-generating study, we focused on the 6073 
CpGs with robust evidence for association with sustained maternal 
smoking in pregnancy from a previous meta-analysis.5 We categor-
ized maternal smoking in well-defined time windows. We examined 
dose effects among sustained smokers only. We additionally ex-
plored associations of paternal smoking with DNA methylation at 
these maternal smoking-associated CpGs.
Methods
Study Design
The analyses were embedded in the Generation R Study, a 
population-based prospective cohort study from fetal life on-
wards.11 The Medical Ethical Committee of Erasmus MC approved 
the study (MEC 198.782/2001/31). Pregnant women with an ex-
pected delivery date between April 2002 and January 2006 living 
in Rotterdam were eligible to participate and 9778 women were in-
cluded. We obtained written informed consent for all participants. 
In a subgroup of 1396 newborns, we measured cord blood genome-
wide DNA methylation.
Here, we included newborns with complete information on DNA 
methylation, parental smoking during pregnancy and covariates. For 
the 15 mothers with two (nontwin) children in the analysis, we ex-
cluded one child by selecting on data completeness (N = 5) or, if both 
complete (N = 10), randomly (Supplementary Figure 1).
Parental Smoking
As described previously, information on maternal smoking before 
and during pregnancy was collected through three questionnaires.3 
Mothers reported on smoking timing and daily cigarette dose, in 
six categories ranging from <1 to >20 per day, at gestational ages 
<18 weeks (early pregnancy), 18–25 weeks (midpregnancy), and ≥25 
weeks (late pregnancy). We constructed one variable describing ma-
ternal smoking behavior based on the answers in the three question-
naires: never smoker (reference); former smoker (quit smoking at 
any time before pregnancy); early quitter (quit smoking when preg-
nancy was known); and sustained smoker (smoked in second and/
or third trimester). Among sustained smokers, we recategorized the 
reported daily cigarette dose in the third trimester into <5 and ≥5. 
We constructed one variable describing paternal smoking (biological 
fathers only) based on maternal report on the question if the father 
smoked. Previous analyses showed a good agreement with paternal 
self-report.12
DNA Methylation
We used the salting-out method to extract DNA from cord blood 
samples. Five-hundred nanograms of DNA was bisulfite converted 
using the EZ-96 DNA Methylation kit (Shallow) (Zymo Research 
Corporation, Irvine, CA). Samples were processed with the Illumina 
Infinium HumanMethylation450 BeadChip (Illumina Inc., San 
Diego, CA). Quality control and normalization were performed 
using the CPACOR workflow.13 Probes with a detection p-value ≥ 
1E-16 were set to missing. Intensity values were quantile normalized. 
Arrays with technical problems, a call rate ≤ 95%, or a mismatch 
between sex of the proband and sex determined by chromosome X 
and Y probe intensities were removed. The final DNA methylation 
data set contained information on 458 563 CpGs, including 5915 of 
the 6073 CpGs associated with sustained smoking in the published 
meta-analysis.5 We used untransformed beta-values as measures of 
DNA methylation.
Covariates
Directed acyclic graphs are presented in Supplementary Figure 
2a and b. We obtained information on parental age, parental pre-
pregnancy body mass index (BMI), maternal education, and parity 
from questionnaires, and newborn sex and birthweight (sex and ges-
tational age-adjusted standard deviation scores) from midwife and 
hospital records.14 We compared newborns included in the study 
with those not included.
Statistical Analysis
We used linear regression models to analyze associations of pre-
natal smoke exposure (maternal smoking: timing and dose; paternal 
smoking: any) and cord blood DNA methylation at the 5915 pre-
viously identified maternal smoking-related CpGs available in our 
data set.5 Analyses of smoking dose were conducted among sus-
tained smokers only, comparing high (≥5) to low (<5) daily cigarette 
doses during the third trimester. In a trend test, we analyzed dose as a 
continuous variable, using never smokers, former smokers, and early 
quitters combined as the reference. We studied paternal smoking 
during pregnancy (biological fathers only), first among newborns 
with nonsmoking mothers. Second, to ensure that this selection did 
not bias the results, we included all newborns, adjusting for maternal 
smoking status.
We ran multiple models using R 3.6.1 (R Core Team, 2013). 
First, crude models were adjusted for batch (plate number) and 
white blood cell types (CD4+ and CD8+ T-lymphocytes, natural 
killer cells, B-lymphocytes, monocytes, granulocytes) estimated by 
the cord-blood specific “Gervin” reference panel.15,16 Second, the 
main models were additionally adjusted for maternal age and educa-
tion, parity, and sex.5 The paternal smoking model was additionally 
adjusted for paternal age, and in the analysis among all newborns 
also for maternal smoking (sustained vs. nonsustained). Third, the 
main models were additionally adjusted for maternal BMI and the 
paternal model also for paternal BMI. Fourth, the main models were 
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DNA methylation levels differ per cell type; therefore, correc-
tion for estimated white blood cell subtypes is needed. There is no 
consensus on which cord-blood specific reference panel should be 
used for cell type estimation. To ensure robust results, independent 
of the reference panel, we repeated the main timing analysis using 
the “Bakulski” 17 rather than the “Gervin” panel,15 as well as without 
cell-type adjustment. The “Bakulski” panel includes the six white 
blood cell subtypes from the “Gervin” panel plus nucleated red 
blood cells.
For all analyses, we calculated the correlations between the effect 
estimates of the main models versus all other models. For the sig-
nificant CpGs of the main model, we calculated the change in effect 
estimates in the BMI and birthweight model.
We accounted for multiple testing by applying the false discovery 
rate (FDR) method of Benjamini and Hochberg.18 Associations with 
FDR-corrected p-values of <.05 were taken forward.
Results
Participant Characteristics
Participant characteristics are shown in Table 1 and Supplementary 
Table 1. Newborns included in the analyses less often had a sus-
tained smoking mother or smoking father, compared with those not 
included. Furthermore, they had older parents and higher educated 
mothers with slightly lower BMI (Supplementary Table 2).
Timing
In the main model, sustained maternal smoking during pregnancy 
was associated with newborn DNA methylation at 1391 CpGs, 
compared with never smokers (Table 2; Supplementary Table 3a). 
Of these, 941 CpGs (67.6%) had lower DNA methylation levels. 
Cg05575921 (AHRR) showed the strongest association, with a 
6.9% lower DNA methylation level (standard error  =  0.4, FDR 
p-value = 2.11E-67). Neither quitting smoking early in pregnancy 
(smallest FDR p-value  =  .08) nor former smoking (smallest FDR 
p-value  =  .63) was associated with newborn DNA methylation, 
compared with never smoking in any of the models (Supplementary 
Table 3b and c).
When compared with the main model, additional adjustment 
for BMI or birthweight decreased the number of associated CpGs 
to 988 and 1206, respectively. For the 1391 CpGs associated with 
sustained maternal smoking, the mean change in effect estimates 
was 9.5% in the BMI model and 5.1% in the birthweight model. 
Results of the Bakulski-adjusted model and model without cell-type 
adjustment were very similar (Supplementary Table 3a–c). For all 
analyses, there were strong correlations between the effect estimates 
of the sensitivity models when compared with the main models (r 
> .92, p < .001).
Dose
Among 157 sustained smoking mothers, the third-trimester dose 
ranged between <1 and >20 cigarettes/d (Supplementary Table 
1). Smoking ≥5 cigarettes (N  =  76) was associated with newborn 
DNA methylation levels at seven CpGs in the main model (smallest 
FDR p-value =  .001), when compared with smoking <5 cigarettes 
(N = 81): cg05575921 (AHRR), cg11641006 (ARL4C), cg07339236 
(ATP9A), cg01621764 (ACTL9), cg04180046 (MYO1G), 
cg12803068 (MYO1G), and cg22377963 (BCL7C) (Supplementary 
Table 3d; Supplementary Figure 3). The trend analysis among 1260 
newborns (1103 with nonsmoking mother) showed evidence toward 
Table 1. Characteristics of the study population

























Maternal age (y) 31.7 (4.2) 32.0 (3.9) 31.9 (3.9) 31.5 (4.2) 30.3 (5.5) 31.9 (3.9) 32.1 (3.8) 31.5 (4.0)
Maternal BMI  
(kg/m2)
23.2 (3.8) 23.3 (3.9) 23.5 (3.9) 22.5 (2.9) 23.2 (4.1) 23.4 (3.9) 23.2 (3.8) 23.7 (4.1)
Maternal education2
 Low 441 (35.0) 205 (29.0) 84 (33.5) 40 (32.0) 112 (63.3) 282 (30.1) 186 (28.4) 96 (34.0) 
 High 820 (65.0) 503 (71.0) 167 (66.5) 85 (68.0) 65 (36.7) 656 (69.9) 470 (72.6) 186 (66.0)
Parity
 Nulliparous 764 (60.6) 414 (58.5) 166 (66.1) 88 (70.4) 96 (54.2) 570 (60.8) 382 (58.2) 188 (66.7)
 Multiparous 497 (39.4) 294 (41.5) 85 (33.9) 37 (29.6) 81 (45.8) 368 (39.2) 274 (41.8) 94 (33.3)
Newborn sex
 Male 640 (50.8) 345 (48.7) 130 (51.8) 61 (48.8) 104 (58.8) 467 (49.8) 317 (48.3) 150 (53.2)
 Female 621 (49.2) 363 (51.3) 121 (48.2) 64 (51.2) 73 (41.2) 471 (50.2) 339 (51.7) 132 (46.8)
Birth weight SDS3 0.10 (0.99) 0.16 (0.95) 0.17 (0.97) 0.18 (0.97) −0.33(1.06) 0.17 (0.96) 0.20 (0.95) 0.09 (0.95)
Paternal age (y)      34.2 (4.9) 34.4 (4.9) 33.6 (4.8)
Paternal BMI  
(kg/m2)
     25.2 (3.1) 25.1 (3.1) 25.2 (3.1)
Table displays characteristics of participants included in the main models of the maternal smoking timing analysis and the paternal smoking analysis. For charac-
teristics of participants included in the dose analysis, see Supplementary Table 1. Values are mean (standard deviation) or N (percentage). (1) Analysis of paternal 
smoking among newborns with never or former smoking mothers only. For results of the sensitivity analysis among all newborns, see Supplementary Table 3e. (2) 
Highest completed education, categorized into lower (secondary education or less) versus higher (more than secondary education). (3) Birthweight corrected for 
sex and gestational age at birth.14 Missing data: maternal smoking timing (N = 135), paternal smoking (N = 458), maternal BMI (N = 205), maternal education 
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a dose effect at 1167 CpGs (smallest FDR p for trend 1.85E-87 for 
cg05575921 [AHRR]).
Paternal Smoking
Among 938 newborns with a never smoking or former smoking 
mother, 282 had a smoking father. Paternal smoking during preg-
nancy was not associated with DNA methylation in the main model 
(smallest FDR p-value = .54; Supplementary Table 3e). A sensitivity 
analysis among 1221 newborns (483 with smoking father), adjusting 
for maternal smoking status, showed similar results (Supplementary 
Table 3e).
Discussion
These analyses suggest that newborn DNA methylation levels at 
CpGs associated with sustained maternal smoking are not associated 
with former maternal smoking or quitting smoking early in preg-
nancy. We observed some evidence of dose effects among sustained 
smoking mothers during the third trimester. Paternal smoking was 
not associated with newborn DNA methylation at these CpGs.
Timing
Fetal changes in DNA methylation might underlie the known asso-
ciations of maternal smoking during pregnancy with adverse health 
outcomes in the children.1,2 A  meta-analysis reported associations 
of sustained maternal smoking during pregnancy with over 6000 
CpGs.5 Here, sustained maternal smoking during pregnancy was as-
sociated with newborn DNA methylation at 24% of the 5915 evalu-
ated CpGs. Among these was the consistently reported cg05575921 
(AHRR).5,7–9 Aryl-Hydrocarbon Receptor Repressor is a tran-
scription factor, part of the aryl hydrocarbon receptor signaling 
pathway, involved in the detoxification of toxins such as dioxin and 
polyaromatic hydrocarbons, both substances of cigarette smoke.8 
The fact that we found no associations for 76% of the evaluated 
CpGs most likely reflects the smaller sample size in this study when 
compared with the meta-analysis.5
Neither maternal former smoking nor quitting smoking in early 
pregnancy was associated with newborn DNA methylation at these 
CpGs. As we only analyzed CpGs known to be associated with 
sustained smoking, we could not detect CpGs specifically associ-
ated with former smoking or early quitting, but not with sustained 
smoking. Our results are largely in line with previous studies.6–10 
Four of these studies observed associations of sustained smoking 
with newborn DNA methylation.6–8,10 Of the two studies that in-
cluded analyses of early quitting,6,10 one did not observe any as-
sociations of early quitting with DNA methylation.10 The other 
study reported a single CpG, cg01290904 (EVC) specifically as-
sociated with early quitting in a Japanese population.6 This CpG 
was not among the 5915 CpGs analyzed in our study, but it was 
found to be associated with adult former smoking in a large EWAS 
meta-analysis.19
Our analyses suggest that quitting smoking earlier in pregnancy 
may still generate benefit in terms of associations with newborn 
DNA methylation at CpGs associated with sustained smoking. 
Future studies should explore whether this results from a lower cu-
mulative dose or less exposure during a critical period in pregnancy. 
Whether smoking earlier in pregnancy is associated with DNA 
methylation at other CpGs not studied here remains to be elucidated.
Dose
Previous studies showed associations of the number of cigarettes 
smoked by pregnant women with fetal growth and birth weight, 
suggesting a dose–response association.1,2 Four EWAS examined 
and found dose effects for some CpGs.7–10 We observed evidence 
for dose–response effects in late pregnancy at seven CpGs and a 
trend toward dose-dependent associations at 1167 CpGs. Except 
for cg01621764 (ACTL9) and cg22377963 (BCL7C), the dose-
associated CpGs in our study have been examined in relation 
Table 2. Associations of sustained maternal smoking during pregnancy with newborn DNA methylation, when compared with 
never smoking
CpG Mapped gene Nearest gene (within 10 Mb) Effect estimate (beta) Standard error p-value p-value (FDR)
cg05575921 AHRR AHRR −0.069 0.004 3.57E-71 2.11E-67
cg18316974 GFI1 GFI1 −0.059 0.004 8.69E-37 2.57E-33
cg04180046 MYO1G MYO1G 0.051 0.004 1.09E-29 2.15E-26
cg12803068 MYO1G MYO1G 0.068 0.006 4.18E-28 6.18E-25
cg09935388 GFI1 GFI1 −0.083 0.008 1.21E-26 1.43E-23
cg14179389 GFI1 GFI1 −0.064 0.007 5.85E-22 5.77E-19
cg06338710 GFI1 GFI1 −0.044 0.005 2.07E-21 1.75E-18
cg25949550 CNTNAP2 CNTNAP2 −0.023 0.002 3.41E-21 2.52E-18
cg22132788 MYO1G MYO1G 0.039 0.004 1.45E-19 9.52E-17
cg12876356 GFI1 GFI1 −0.085 0.010 7.68E-18 4.54E-15
cg18146737 GFI1 GFI1 −0.098 0.012 5.35E-16 2.87E-13
cg23067299 AHRR AHRR 0.033 0.004 1.26E-15 6.21E-13
cg19089201 MYO1G MYO1G 0.028 0.004 2.97E-15 1.35E-12
cg21161138 AHRR AHRR −0.022 0.003 9.93E-14 4.19E-11
cg11902777 AHRR AHRR −0.015 0.002 5.28E-13 2.08E-10
cg09662411 GFI1 GFI1 −0.050 0.007 7.81E-12 2.89E-09
cg04598670 — AUTS2 −0.031 0.005 1.14E-11 3.96E-09
cg08606254 AHRR AHRR 0.022 0.003 4.62E-11 1.52E-08
cg22549041 CYP1A1 CYP1A1 0.055 0.008 8.46E-11 2.63E-08
cg14817490 AHRR AHRR −0.025 0.004 9.16E-11 2.71E-08
cg18703066 — — −0.011 0.002 3.15E-10 8.87E-08
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to maternal smoking dose previously.7–9 Of these, cg05575921 
(AHRR), cg07339236 (ATP9A), cg04180046 (MYO1G), and 
cg12803068 (MYO1G) showed a tendency toward dose-dependent 
associations in at least two studies.7–9
Paternal Smoking
Like maternal smoking, paternal smoking has been associated 
with adverse child health outcomes.2,3,20 If these associations are 
mediated through DNA methylation, this could either reflect 
transmission through effects on the sperm epigenome, or in utero 
exposure to secondhand smoke.10 In line with a previous study, 
focusing on a small number of CpGs, we observed no associ-
ations of paternal smoking with newborn DNA methylation at 
CpGs associated with sustained maternal smoking, independent 
of the mother’s smoking status.10 A recent full EWAS did report 
evidence for associations of paternal smoking with differential 
DNA methylation in offspring at older ages, after adjustment 
for maternal smoking.21 This indicates that there may be CpG 
sites at which DNA methylation is specifically related to paternal 
smoking.
Strengths and Limitations
This study was embedded in a large population-based prospective 
cohort study, and the sample size for DNA methylation was 
relatively large. However, this study may still not be adequately 
powered to find small effects. Therefore, our results should be con-
sidered as hypothesis generating. Because of power, we only in-
cluded CpGs previously identified in relation to sustained maternal 
smoking. Consequently, we may have failed to detect CpGs spe-
cifically associated with maternal smoking earlier in pregnancy or 
with paternal smoking. The Generation R Study provided 13% of 
the meta-analysis sample size, so has contributed to the discovery 
of the CpGs of interest.5 As DNA methylation is tissue specific, 
the relevance of findings in blood in relation to other tissues needs 
further study. For example, maternal smoking during pregnancy 
has been associated with childhood asthma.1 To better understand 
the role of DNA methylation in this, analyses of DNA methyla-
tion in lung tissue, which may be more relevant for respiratory 
phenotypes, should be performed. This study included relatively 
few heavy smokers, most smokers consumed low doses and vari-
ation in dose was limited. Furthermore, there may be measurement 
error in dose, as women may not have accurately reported small 
differences in daily smoking dose. These factors may have led to 
underestimation of any dose–response effects.
Conclusion
Our results indicate that CpGs robustly associated with sustained 
maternal smoking are not associated with maternal smoking earlier 
in pregnancy or with paternal smoking and that the association 
with sustained maternal smoking shows dose effects at some CpGs. 
Further research is needed to study the relevance of DNA methyla-
tion for clinical outcomes.
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